Business
PAOG Announces Imminent Launch Of First CBD Nutraceutical Product Line - Q4 Sales Projected With Rapid Revenue Growth Anticipated To Follow
PAOG Announces Imminent Launch Of First CBD Nutraceutical Product Line - Q4 Sales Projected With Rapid Revenue Growth Anticipated To Follow.
About this update from Pao Group, Inc.
[{"type":"text","content":"\n\n\n\nPAOG Announces Imminent Launch Of First CBD Nutraceutical Product Line - Q4 Sales Projected With Rapid Revenue Growth Anticipated To Follow\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nPAOG Announces Imminent Launch Of First CBD Nutraceutical Product Line - Q4 Sales Projected With Rapid Revenue Growth Anticipated To Follow\nPR Newswire\nSANDUSKY, Ohio, Oct. 12, 2021\n\n\n\nSANDUSKY, Ohio, Oct. 12, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today announced the company expects to realize its first CBD nutraceutical product sales beginning imminently in Q4, 2021.\nThe company confirms shipping its first CBD nutraceutical product to its distribution partner, North American Cannabis Holdings, Inc. (USOTC: USMJ).\nPAOG plans to announce specifics about its first CBD nutraceutical product in an upcoming formal product launch announcement once the distributor is set up to begin sales and distribution.\nPAOG expects revenue to grow rapidly following its first CBD nutraceutical product launch as the company has follow on products lined up to follow the first product adding to overall sales potential.\nPAOG is developing CBD pharmaceuticals and nutraceuticals from its intellectual property associated with a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled \"METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.\"\nThe 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion, and it is expected to reach $16.4 Billion by 2027.\nLearn more about USMJ's ecommerce site at www.usmj.com.\nLearn more about PAOG at www.paogroupinc.com.\nForward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the co...